M K Proteins Limited has informed the Exchange regarding appointment of Internal Auditor and Cost Auditor of the Company for FY 2026-27
MKPL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
M K Proteins Limited reported audited standalone financial results for Q4 and FY ended March 31, 2026. Revenue from operations grew 43% to Rs. 38,287.52 Lakhs from Rs. 26,770.60 Lakhs in the previous year. However, profit after tax declined 18.7% to Rs. 682.90 Lakhs from Rs. 839.74 Lakhs, and EPS dropped to Rs. 0.18 from Rs. 0.22. The Board re-appointed M/s K. K. Sinha & Associates as Cost Auditor and M/s Jayant Bansal & Co. as Internal Auditor for FY 2026-27. Outstanding qualified borrowings reduced to Rs. 36.19 Crores from Rs. 37.75 Crores. The company maintained an 'A' credit rating from CRISIL for both long-term and short-term bank facilities. The statutory auditor issued an unmodified opinion on the financial statements.
Strong top-line growth was offset by declining profitability, which may concern investors focused on margins. The reduction in debt and maintained credit rating are positives. The appointment of auditors is routine and signals normal governance functioning.